These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Tigason in the treatment of psoriasis and various dermatoses]. Kalamkarian AA; Marzeeva GI; Chistiakova IA; Kirsanova MM; Mel'kumov AV Vestn Dermatol Venerol; 1985 Jul; (7):4-7. PubMed ID: 4050091 [No Abstract] [Full Text] [Related]
6. Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason). Grupper C; Berretti B Dermatologica; 1981; 162(5):404-13. PubMed ID: 7250475 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis. Thirumoorthy T; Tham SN; Tan YC J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270 [No Abstract] [Full Text] [Related]
8. [Therapeutic assessment and side-effects of the aromatic retinoid on the nail apparatus]. Baran R Ann Dermatol Venereol; 1982; 109(4):367-71. PubMed ID: 7125489 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses. Viglioglia PA Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314 [TBL] [Abstract][Full Text] [Related]
11. Influence of retinoid Ro 10-9359 on cell-mediated immunity in vivo. Fulton RA; Souteyrand P; Thivolet J Dermatologica; 1982; 165(6):568-72. PubMed ID: 7169132 [TBL] [Abstract][Full Text] [Related]
12. Response of psoriatic nails to the aromatic retinoid etretinate. Rabinovitz HS; Scher RK; Shupack JL Arch Dermatol; 1983 Aug; 119(8):627-8. PubMed ID: 6870312 [No Abstract] [Full Text] [Related]
13. Tigason (etretinate) treatment in psoriatic arthritis. Ciompi ML; Bazzichi L; Marotta G; Pasero G Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251 [TBL] [Abstract][Full Text] [Related]
14. Histologic changes in the liver during etretinate treatment. Foged E; Bjerring P; Kragballe K; Søgaard H; Zachariae H J Am Acad Dermatol; 1984 Oct; 11(4 Pt 1):580-3. PubMed ID: 6490982 [TBL] [Abstract][Full Text] [Related]
15. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients. Mahrle G; Meyer-Hamme S; Ippen H Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226 [TBL] [Abstract][Full Text] [Related]
16. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. Findlay GH S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876 [TBL] [Abstract][Full Text] [Related]
17. Etretinate (Tigason) for skin disease. Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967 [No Abstract] [Full Text] [Related]
18. [Aromatic retinoid (Ro-10) in the treatment of palmoplantar psoriasis pustulosa (author's transl)]. Deichmann B; Spindeldreier A Z Hautkr; 1982 Mar; 57(6):425-8. PubMed ID: 7080591 [No Abstract] [Full Text] [Related]
19. [Growth of finger nails in psoriasis patients undergoing PUVA therapy]. Landherr G; Braun-Falco O; Hofmann C; Plewig G; Galosi A Hautarzt; 1982 Apr; 33(4):210-3. PubMed ID: 7096084 [TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis]. Gajardo J Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]